Enhanced liver targeting of 5-fluorouracil using galactosylated human serum albumin as a carrier molecule

Journal of Drug Targeting

Volumn 14, Issue 2, 2006, Pages 55-61

  Cai, Chun ^a   Zhou, Keyuan ^a   Wu, Yong ^b   Wu, Linyan ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Asialoglycoprotein receptor; Drug targeting; Galactosylated human serum albumin; Hepatocarcinoma

Indexed keywords

ALBUMIN CONJUGATE; ANTINEOPLASTIC AGENT; ASIALOGLYCOPROTEIN RECEPTOR; FLUOROURACIL GALACTOSYLATED HUMAN SERUM ALBUMIN CONJUGATE; IODINE 131; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TARGETING; DRUG UPTAKE; FEMALE; ISOTOPE LABELING; LIVER CELL CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FLUOROURACIL; GALACTOSE; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; LIVER; MALE; MICE; RABBITS; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TETRAZOLIUM SALTS; THIAZOLES; TISSUE DISTRIBUTION;

EID: 33645886063     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860600613324     Document Type: Article

References (19)

1. Aboagye, EO and Saleem, A and Cunningham, VJ and Osman, S and Price, PM. (2001) Extraction of 5-fluorouracil by tumor and liver: A noninvasive positron emission tomography study of patients with gastrointestinal cancer Cancer Res, 61, pp. 4937-4941.
2. Ashwell and Harford. (1982) Carbohydrate-specific receptor of the liver Ann Rev Biochem, 51, pp. 531-534.
3. Cao, S and Rustum, YM. (2000) Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: Role of drug sequence and dose Cancer Res, 60, pp. 3717-3721.
4. Fata, F and Ron, IG and Kemeny, N and O'Reilly, E and Klimstra, D and Kelsen, DP. (1999) 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma Cancer, 86, pp. 1129-1134.
5. Fiusepppina, DS and Lanza, M and Kratz, F and Merina, L and Fiume, L.(2004) Anovel method for coupling doxorubixin to lactosaminated human albumin by an acid sensitive hydrazone bond: Synthesis, characterization and preliminary biological properties of the conjugate. In (pp. 393-397).
6. Greenwood FC, Hunter WM, Glover JS. 1963. The preparation of 131I labeled human growth hormone of high specific activity Biochemistry 89:114-123
7. Jung, HH and Oh, YK and Kim, DS and Kim, CK.(1999) Enhanced hepatocyte upkate and liver targeting of methotrexate using galactosylated albumin as a carrier. In (pp. 39-47).
8. Kuropkat, C and Griem, K and Clark, J and Rodriguez, ER and Hutchinson, J and Taylor, SG. (1999) Severe cardiotoxicity during 5-fluorouracil chemotherapy: A case and literature report Am J Clin Oncol, 22, pp. 466-470.
9. Lee, YC and Stowell, CP and Krantz, MJ. (1976) 2-Imino-2-methoxyethyl-1-thioglycosides: New reagents for attaching sugars to proteins Biochemistry, 15, pp. 3956-3963.
10. Ogawara, K and Nikiya, M and Takakura, Y and Hashida, M. (1998) Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver J control Rel, 50, pp. 309-317.
11. Qun, D and Liyi, Z and Jinian, F. (1996) Modified phenol- sulfuric acid method for determination of the content of oligo-and polysaccha-rides Chin Pharm, 31, pp. 550-553.
12. Schneider, YJ and Abarca, J and Aboud-Pirak, E and Baurain, R and Ceulemanas, F and Deprez-De Campeneere, D and Lesur, B and Masquelier, M and Otteslachuylder, C and Rolin-van Swieten, D and Trouet, A.(1984) Drug targeting in human cancer chemotherapy. In Receptor-mediated targeting of drugs, NATO ASI series A: Life sciences. (pp. 1-25). Plenum Press: New York.
13. Shochiro, Ozaki and Toshio, Nagase and HiroFUmi, Tamai and Haruki, Mori and Akio, Hoshi and Masaaki, Iigo. (1987) 5-Fluoroucial derivatives. XII. Synthesis and antitumor activity of α-alkylthiomethy-, α-alkylsufinylmethyl-, α-alkylsulfonylmethyl-, and α-acylthiomethyl-5-fluorouracils Chem Pharm Bull, 35(9), pp. 3894-3897.
14. Theresa, MA. (2002) Ligand-targeted therapeutics in anticancer therapy Nature, pp. 2750-2761.
15. Trere, D and Fiume, L and Badiali De, F and Giorgi, L and Di Stefano, G and Migaldi, M and Derenzini, M. (1999) The asialoglycoprotein receptor in human hepatocellular carcinomas: Its expression on proliferating cell Br J Cancer, 81, pp. 404-408.
16. Vaughan, JR, Jr. and Eichler, JA. (1954) Synthesis of optically active hexa and octapeptides, through mixed carbonic-carboxylic acid anhydrides J Am Chem Soc, 76, pp. 2474-2479.
17. Vera, DavidR and Stadalnik, RebertC and Krohn, KennethA. (1985) Technetium-99m galactosyl-neoglycoalbumin: Preparation and preclinical studies J Nucl Med, 26, pp. 1157-1167.
18. Yoshikawa, R and Kusunoki, M and Yanagi, H and Noda, M and Furuyama, JI and Yamamura, T and Hoshimoto-Tamaoki, T. (2001) Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: A novel target mechanism concept for pharmacokinetic modulating chemotherapy Cancer Res, 61, pp. 1029-1037.
19. Zhong, YG and Fu, X and Guan, CT. (1995) Prepare of galactosyl-interferon and its hepatic targeting property Chin J Med Chem, 5(3), pp. 164-168.